Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Otto Hemminki

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Plos One|May 27, 2022
Incidence and survival in laryngeal and lung cancers in Finland and Sweden through a half centuryAnni Koskinen, Otto Hemminki, Asta Försti, et al.
Journal of the National Cancer Institute|April 11, 2018
RE: Familial Cancer Clustering of Urothelial Cancer: A Population-Based Case-Control StudyKari Hemminki, Hongyao Yu, Otto Hemminki, et al.
Journal of Hematology & Oncology|July 1, 2020
Oncolytic viruses for cancer immunotherapyOtto Hemminki, João Manuel Dos Santos, Akseli Hemminki
BMC Cancer|March 3, 2022
Incidence and survival in oral and pharyngeal cancers in Finland and Sweden through half centuryAnni I Koskinen, Otto Hemminki, Asta Försti, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|June 2, 2021
Incidence trends in lung and bladder cancers in the Nordic Countries before and after the smoking epidemicKari Hemminki, Asta Försti, Akseli Hemminki, et al.
Cancers|September 9, 2023
Long-Term Periodic and Conditional Survival Trends in Prostate, Testicular, and Penile Cancers in the Nordic Countries, Marking Timing of ImprovementsFilip Tichanek, Asta Försti, Akseli Hemminki, et al.
BMC Cancer|May 26, 2021
Incidence trends in bladder and lung cancers between Denmark, Finland and Sweden may implicate oral tobacco (snuff/snus) as a possible risk factorKari Hemminki, Asta Försti, Akseli Hemminki, et al.
European Journal of Cancer (Oxford, England : 1990)|April 17, 2023
Survival in melanoma in the nordic countries into the era of targeted and immunological therapiesFilip Tichanek, Asta Försti, Akseli Hemminki, et al.
Clinical Epidemiology|May 8, 2023
Survival in Lung Cancer in the Nordic Countries Through A Half CenturyFilip Tichanek, Asta Försti, Otto Hemminki, et al.
Hereditary Cancer in Clinical Practice|February 27, 2025
High familial risks in some rare cancers may pinpoint to hidden germline genetics: focus on esophageal, stomach, small intestinal, testis, thyroid and bone cancersKari Hemminki, Otto Hemminki, Anni Koskinen, et al.
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Plos One|May 27, 2022
Incidence and survival in laryngeal and lung cancers in Finland and Sweden through a half centuryAnni Koskinen, Otto Hemminki, Asta Försti, et al.
Journal of the National Cancer Institute|April 11, 2018
RE: Familial Cancer Clustering of Urothelial Cancer: A Population-Based Case-Control StudyKari Hemminki, Hongyao Yu, Otto Hemminki, et al.
Journal of Hematology & Oncology|July 1, 2020
Oncolytic viruses for cancer immunotherapyOtto Hemminki, João Manuel Dos Santos, Akseli Hemminki
BMC Cancer|March 3, 2022
Incidence and survival in oral and pharyngeal cancers in Finland and Sweden through half centuryAnni I Koskinen, Otto Hemminki, Asta Försti, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|June 2, 2021
Incidence trends in lung and bladder cancers in the Nordic Countries before and after the smoking epidemicKari Hemminki, Asta Försti, Akseli Hemminki, et al.
Cancers|September 9, 2023
Long-Term Periodic and Conditional Survival Trends in Prostate, Testicular, and Penile Cancers in the Nordic Countries, Marking Timing of ImprovementsFilip Tichanek, Asta Försti, Akseli Hemminki, et al.
BMC Cancer|May 26, 2021
Incidence trends in bladder and lung cancers between Denmark, Finland and Sweden may implicate oral tobacco (snuff/snus) as a possible risk factorKari Hemminki, Asta Försti, Akseli Hemminki, et al.
European Journal of Cancer (Oxford, England : 1990)|April 17, 2023
Survival in melanoma in the nordic countries into the era of targeted and immunological therapiesFilip Tichanek, Asta Försti, Akseli Hemminki, et al.
Clinical Epidemiology|May 8, 2023
Survival in Lung Cancer in the Nordic Countries Through A Half CenturyFilip Tichanek, Asta Försti, Otto Hemminki, et al.
Hereditary Cancer in Clinical Practice|February 27, 2025
High familial risks in some rare cancers may pinpoint to hidden germline genetics: focus on esophageal, stomach, small intestinal, testis, thyroid and bone cancersKari Hemminki, Otto Hemminki, Anni Koskinen, et al.
Pageof 8